Citation

BibTex format

@inproceedings{Fulgenzi:2023:10.1016/j.annonc.2023.04.043,
author = {Fulgenzi, C and D'Alessio, A and Scheiner, B and Ang, C and Wietharn, B and Pinter, M and Nishida, N and Parisi, A and Huang, Y and Bettinger, D and Vogel, A and Silletta, M and Schoenlein, M and Galle, P and Kudo, M and Singal, A and Cortellini, A and Chon, H and Stefanini, B and Giannini, E and Pinato, D},
doi = {10.1016/j.annonc.2023.04.043},
pages = {S7--S7},
publisher = {ELSEVIER},
title = {Atezolizumab plus bevacizumab is associated with improved survival outcomes in HCC patients with Child-Pugh B dysfunction compared to best supportive therapy},
url = {http://dx.doi.org/10.1016/j.annonc.2023.04.043},
year = {2023}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Fulgenzi,C
AU  - D'Alessio,A
AU  - Scheiner,B
AU  - Ang,C
AU  - Wietharn,B
AU  - Pinter,M
AU  - Nishida,N
AU  - Parisi,A
AU  - Huang,Y
AU  - Bettinger,D
AU  - Vogel,A
AU  - Silletta,M
AU  - Schoenlein,M
AU  - Galle,P
AU  - Kudo,M
AU  - Singal,A
AU  - Cortellini,A
AU  - Chon,H
AU  - Stefanini,B
AU  - Giannini,E
AU  - Pinato,D
DO  - 10.1016/j.annonc.2023.04.043
EP  - 7
PB  - ELSEVIER
PY  - 2023///
SN  - 0923-7534
SP  - 7
TI  - Atezolizumab plus bevacizumab is associated with improved survival outcomes in HCC patients with Child-Pugh B dysfunction compared to best supportive therapy
UR  - http://dx.doi.org/10.1016/j.annonc.2023.04.043
ER  -
Download